How Agentic Commercial enables more precise field, digital and content engagement
Creating dialogue with HCPs and patients to help medicines reach them faster.
Biopharma companies have traditionally relied on direct interactions between sales representatives and healthcare professionals, but as therapeutic areas become increasingly specialized, more teams are involved in engaging with HCPs. These teams, including key account managers and brand marketers, often work in silos, creating disjointed experiences for HCPs.
Additionally, biopharma companies are engaging with a broader network of stakeholders, many of whom are using AI to inform their decisions. To address these challenges, biopharmas are adopting Agentic Commercial, which combines AI with field teams, digital channels, and approved content to create more personalized HCP experiences.
This model transforms sales teams into strategic sources of customer intelligence, turning CRM systems into systems of guidance. Agentic call reporting enables reps to capture richer details from HCP conversations, generating actionable insights that reveal treatment barriers. Digital channels extend the dialogue with natural language AI, providing timely responses to questions and generating Commercial Evidence.
Agentic MLR acts as an end-to-end expert reviewer, accelerating content review while maintaining compliance, allowing commercial teams to respond faster to customer questions. By combining AI capabilities with human expertise, Agentic Commercial enables biopharmas to create a more connected and personalized experience across channels, helping patients access the right medicines sooner.
Written by urgent.news from TechRadar's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
